Peruvian FSWs: Understanding HPV and barriers to vaccination

Vaccine

Volumn 28, Issue 49, 2010, Pages 7743-7747

  Brown, Brandon ^a   Carcamo, Cesar ^b   Blas, Magaly M ^b   Valderrama, Maria ^b   Halsey, Neal ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Female; Human papillomavirus vaccine; Sex workers

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER RISK; CANDIDIASIS; CONDYLOMA ACUMINATUM; FEMALE; HEALTH EDUCATION; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTITUTION; SPAIN; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VACCINATION; VAGINITIS; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PERU; PROSTITUTION; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78349312201     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.063     Document Type: Article

References (13)

1. IARC Monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses 2005, vol. 90. International Agency for Research on Cancer, Lyon.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
3. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459.
4. Calhoun B. Feasibility of a community-based voluntary HIV counseling and testing program in commercial sex venues in Lima, Peru. Third annual poster presentation at Puget Sound Partners for Global Health Lecture 2005.
5. Mak R., Van Renterghem L., Cuvelier C. Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect 2004, 80(2):118-120.
6. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006, 95(11):1459-1466.
7. Waller J., McCaffery K., Forrest S., Szarewski A., Cadman L., Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003, 79(4):320-322.
8. Kwan T.T., Chan K.K., Yip A.M., Tam K.F., Cheung A.N., Young P.M., et al. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study. Sex Transm Infect 2008, 84(3):227-232.
9. Marlow L.A., Waller J., Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer 2007, 97(5):691-694.
10. Kietpeerakool C., Phianmongkhol Y., Jitvatcharanun K., Siriratwatakul U., Srisomboon J. Knowledge, awareness, and attitudes of female sex workers toward HPV infection, cervical cancer, and cervical smears in Thailand. J Gynecol Obstet 2007, 107(3):216-219.
11. Etcheverry M.F., de Lazzari E., Fuchs J.D., Meroño M., Sierra E., Del Romero J., et al. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain. AIDS Behav 2010, 14(3):607-617.
12. Djomand G., Metch B., Zorrilla C.D., Donastorg Y., Casapia M., Villafana T., et al. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr 2008, 48(1):82-89.
13. Barroso P.F., de Souza M.B., do Lago R.F., Pedrosa J., Yoshida C.B., Faulhaber J.C., et al. Barriers to recruit female commercial sex workers for HIV vaccine trials: the Rio de Janeiro experience. J Acquir Immune Defic Syndr 2009, 50(1):116-117.